Also Cyp has treated 165 patients in Osteoarthritis without generating an adverse event worthy of reporting. And these 165 patients received multiple injections. So we’re looking at close to 400 doses of Cymerus cells without triggering an event that would halt recruitment.
Ann: Encouraging Initial Data from CYP-006TK DFU Trial, page-41
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.72M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.0¢ | 21.0¢ | $24.71K | 115.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 33964 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 2225 | 1 |
View Market Depth
| Last trade - 15.41pm 09/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |